Successful treatment of differentiated thyroid carcinoma with transaxillary robotic surgery and radioiodine: The first European experience
European Thyroid Journal Mar 02, 2018
Balay MA, et al. - Researchers here reported the oncological outcomes of transaxillary robotic thyroidectomy surgery (TARS) followed by radioiodine (RAI) therapy in patients with differentiated thyroid carcinoma. Outcomes suggested TARS followed by RAI therapy to be curative, even for patients with lymph node metastases, after good preoperative staging.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
